Skip to content

HealthEquity HQY Cumulative Cost Basis

Cumulative Cost Basis at other companies

UnitedHealth Group logo
UnitedHealth GroupUNH
MetLife logo
MetLifeMET
Oscar Health logo
Oscar HealthOSCR

Other financials

Income statement

See full
Revenue$354.6M+7.2%
Gross profit$256.3M+14.3%
Operating income$103.0M+23.9%
Net income$69.4M+28.8%
EPS (diluted)$0.82+34.4%

Balance sheet

See full
Cash & equivalents$265.4M-7.8%
Total debt$984.7M-11.0%
Total equity$2.0B-3.6%
Total assets$3.3B-3.2%

Cash flow

See full
Operating cash flow$97.5M+50.6%
CapEx$362.0K+321%
Free cash flow$97.2M+50.3%

Valuation

See full
Market cap$7.12B-6.7%
Enterprise value$7.84B-7.2%
P/E30.9×-31.8×
P/S5.3×-0.8×

Profitability

See full
Gross margin70.7%+5.2pp
Operating margin25.6%+9.2pp
Net margin17.3%+7.5pp
FCF margin36.5%+9.3pp

Returns & leverage

See full
Return on equity11.1%+5.3pp
Debt / equity0.5×0.0×
Current ratio3.4×-0.6×

Where this comes from

Reported directly by HealthEquity in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.

The official record: HealthEquity’s 10-Q, filed May 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about HealthEquity's cumulative cost basis.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is HealthEquity's cumulative cost basis?
HealthEquity (HQY) reported cumulative cost basis of $41.52M in Q1 2026.
How has HealthEquity's cumulative cost basis changed year-over-year?
HealthEquity's cumulative cost basis increased by 5.1% year-over-year, from $39.49M to $41.52M.
What is the long-term trend for HealthEquity's cumulative cost basis?
Over 5 years (2021 to 2026), HealthEquity's cumulative cost basis has grown at a -7.6% compound annual growth rate (CAGR), from $60.09M to $40.5M.